Table 3.
Established AKI (n = 65) | Later-onset AKI (n = 66) | AKI progression (n = 84) | |
---|---|---|---|
Semaphorin 3A (ng/gCre) | 0.64 [0.56–0.71] | 0.71 [0.64–0.78] | 0.71 [0.64–0.77] |
L-FABP (μg/gCre) | 0.76 [0.69–0.82]# | 0.73 [0.66–0.79] | 0.71 [0.64–0.77] |
NGAL (μg/gCre) | 0.78 [0.70–0.84]# | 0.66 [0.59–0.73] | 0.66 [0.59–0.73] |
IL-18 (ng/gCre) | 0.78 [0.71–0.84]# | 0.70 [0.62–0.77] | 0.68 [0.62–0.75] |
Alb (mg/gCre) | 0.78 [0.70–0.84] | 0.70 [0.62–0.77] | 0.68 [0.59–0.72] |
NAG (IU/gCre) | 0.67 [0.60–0.74] | 0.68 [0.60–0.74] | 0.66 [0.59–0.72] |
Serum creatinine at ICU admission (mg/dl) | 0.80 [0.75–0.84] | 0.68 [0.61–0.75] | 0.64 [0.57–0.70] |
Values are presented as AUC-ROC [95% confidence interval]. #P<0.05 vs. Semaphorin 3A.
AUC; area under the curve.